Canaccord Genuity analyst Caitlin Cronin has maintained their bullish stance on KRMD stock, giving a Buy rating on November 14.Don't Miss our ...

Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only ...

The enforcement action came after the healthcare facility failed to settle significant debts owed to its workforce and ...

We've found four incredible coffee machines with big savings in the Amazon Black Friday sale - but they’ll soon be gone ...

Modeled after the state’s $6 billion cancer research fund, the dementia fund — a legislative priority for Lt. Gov. Dan ...

Of the 50 startups on Foresight Canada’s 2024 list of the most investable cleantech startups, half are B.C. companies, six of ...

Luke’s would provide an infusion of capital but did not share how much would be added ... Additionally, a team of researchers from THI, BCM and Texas Children’s Hospital secured funding for a new ...

Although the 2015 Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical ...

The "Infusion Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's ...

Commentary: Social media users correctly spotted my misdiagnosis. Here are two diabetes tech wearables everyone should know ...

Ritesh Agarwal, Founder and CEO of hospitality management platform OYO is set to invest an additional Rs 550 crore.

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...